Search results for "LEED"

showing 10 items of 267 documents

Acquired haemophilia in cancer: A systematic and critical literature review

2017

Aim There is a paucity of data on the clinical presentation and management of cancer patients with acquired haemophilia (AH), we here report a systematic literature review on acquired haemophilia in the context of cancer. Methods Treatment outcomes of AH were defined as complete response (CR), partial response (PR) or no response (NR), based on inhibitor eradication, coagulation factor VIII levels and bleeding control. Reported deaths were either related to cancer or bleeding. Results Overall, 105 cases were collected and analyzed according to classification of cancer and efficacy of treatments for inhibitor and malignancy. The mean age was 68 years for both males (range 37-86 years) and fe…

medicine.medical_specialtyContext (language use)Antineoplastic AgentsFactor VIIa030204 cardiovascular system & hematologyMalignancyHemophilia AGastroenterology03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesInternal medicineNeoplasmsAcquired haemophiliamedicineHumanscancerhaematological malignancyGenetics (clinical)Blood Coagulation Factor Inhibitorstreatmentbusiness.industryIncidence (epidemiology)AutoantibodyCancerHematologyGeneral Medicinemedicine.diseasebleedingBlood Coagulation FactorsRecombinant ProteinsSurgeryinhibitordiagnosiSystematic reviewTreatment Outcome030220 oncology & carcinogenesisHematologic Neoplasmsacquired haemophilabusinessHaematological malignancy
researchProduct

The critical view of safety during laparoscopic cholecystectomy: Strasberg Yes or No? An Italian Multicentre study

2020

Abstract Background Laparoscopic cholecystectomy is considered the gold standard for the treatment of gallbladder lithiasis; nevertheless, the incidence of bile duct injuries (BDI) is still high (0.3–0.8%) compared to open cholecystectomy (0.2%). In 1995, Strasberg introduced the "Critical View of Safety" (CVS) to reduce the risk of BDI. Despite its widespread use, the scientific evidence supporting this technique to prevent BDI is controversial. Methods Between March 2017 and March 2019, the data of patients submitted to laparoscopic cholecystectomy in 30 Italian surgical departments were collected on a national database. A survey was submitted to all members of Italian Digestive Pathology…

medicine.medical_specialtyCritical view of safetymedicine.medical_treatmentLaparoscopic trainingbBile duct injuriesBile duct injuries; Cholecystectomy; Critical view of safety; Intraoperative bleeding; Laparoscopic training; LaparoscopyBile Duct DiseasesArticlebBile duct injuries; cholecystectomy; critical view of safety; intraoperative bleeding; laparoscopic training; laparoscopyMedicineHumansCholecystectomyLaparoscopyIntraoperative ComplicationsIntraoperative bleedingmedicine.diagnostic_testbusiness.industryBile ductGeneral surgeryGallbladderIncidence (epidemiology)Gold standardGallbladderPerioperativeBile duct injuriesmedicine.anatomical_structureCholecystectomy LaparoscopicItalySurgeryCholecystectomyLaparoscopyBile DuctsbusinessBile duct injurieAbdominal surgery
researchProduct

Outcomes of monopolar versus bipolar endometrial ablation on uterine bleeding and psychophysical wellbeing.

2017

Background To compare outcomes of endometrial ablation with monopolar versus bipolar resection on uterine bleeding and psychophysical wellbeing. Methods In a prospective randomized study, 100 perimenopausal patients, without desire of pregnancy and with no response to pharmacological treatment, underwent endometrial ablation from 2012 to 2014. They were randomly divided in two groups: 50 patients treated with monopolar electrode resection loop (group A) and 50 patients treated with bipolar electrode resection loop (group B). Operative parameters were immediately assessed. Menstrual outcome parameters and psycho-physical well-being parameters were evaluated after 12 months. Results No signif…

medicine.medical_specialtyEndometrial ablation techniquemedicine.medical_treatmentElectrodeOperative TimeHysteroscopy030204 cardiovascular system & hematologyResectionlaw.invention03 medical and health sciences0302 clinical medicinePostoperative ComplicationsRandomized controlled triallawmedicineHumansProspective randomized studyProspective StudiesProspective cohort studyElectrodesEndometrial Ablation TechniquesPregnancybusiness.industryUterine bleedingObstetrics and GynecologyMiddle Agedmedicine.diseaseSurgeryPerimenopauseProspective StudieTreatment OutcomePremenopause030220 oncology & carcinogenesisEndometrial ablationFemalePostoperative ComplicationUterine HemorrhageComplicationbusinessHumanMinerva ginecologica
researchProduct

Efficacy and Safety of IQYMUNE®, a Ten Percent Intravenous Immunoglobulin in Adult Patients With Chronic, Primary Immune Thrombocytopenia

2018

Background: Intravenous immunoglobulin (IVIG) IQYMUNE® is a highly purified 10% IVIG that was assessed using the new stringent definition of response described in the revised guideline on the clinical investigation of IVIG. The efficacy and the safety of IQYMUNE® were investigated in adult patients with chronic primary immune thrombocytopenia (ITP). Methods: In this phase III multinational, multicentre, prospective, uncontrolled, open-label, single-arm study, adult patients with a baseline platelet count < 30 × 10 9 /L were treated with IVIG 10% at a dose of 2 g/kg body weight administered over 2 consecutive days. The primary endpoint was Response over the study period and was defined accor…

medicine.medical_specialtyEuropean Medicines Agency guidelinesPlatelet countRenal functionHigh dose030204 cardiovascular system & hematologyGastroenterology03 medical and health sciencesIntravenous immunoglobulin; High dose; Immune thrombocytopenia; Response; European Medicines Agency guidelines; Platelet count; Bleeding assessment; Infusion rate0302 clinical medicineInfusion rateInternal medicinemedicineClinical endpointPlateletAdverse effectIntravenous immunoglobulinbiologybusiness.industryResponseGuidelineImmune thrombocytopeniaImmune thrombocytopenia030220 oncology & carcinogenesisConcomitantbiology.proteinBleeding assessmentOriginal ArticleAntibodybusinessJournal of Hematology
researchProduct

Management of the Sponataneous Bleeding Episodes in Factor VII Deficiency. A Prospective Evaluation of the STER,

2011

Abstract Abstract 3368 Introduction Patients with an inherited factor VII (FVII) deficiency may display a wide range of clinical phenotypes, from an asymptomatic condition to serious hemorrhagic episodes such as fatal central nervous system (CNS) or gastrointestinal (GI) bleeds (Mariani G et al. Thromb Haemost 2005; 93: 481–7). Symptomatic patients can be divided into two major categories: those with mild-to-moderate bleeding tendency and individuals with a severe bleeding tendency which may be more severe than that in hemophilia. The former group mainly experience mucosal bleeding, a clinical picture that mimics that of a platelet disorder and often does not call for treatment. In contrast…

medicine.medical_specialtyFactor VIIbusiness.industryPlatelet disorderImmunologyCell BiologyHematologyBleedmedicine.diseaseHaemophiliaBiochemistryAsymptomaticGastroenterologySurgerychemistry.chemical_compoundHematomaHemophiliaschemistryInternal medicinemedicineFresh frozen plasmamedicine.symptombusinessBlood
researchProduct

Prognostic Impact of 3-HM Concentration in Patients with Alcoholic or Viral Cirrhosis

2018

The role of endotoxemia related to intestinal bacterial translocation in worsening liver disease is the subject of many studies, but its impact on cirrhosis mortality has not been well evaluated. In this study, 3-hydroxymyristate (3-HM) (specific lipid of lipopolysaccharides) was directly quantified by an innovative patented assay with the aim of assessing the impact on cirrhosis mortality. The 3-HM concentration was measured in 593 patients with alcoholic or viral cirrhosis in stable clinical condition. A Cox hazards regression model was used to evaluate association between 3-HM and its fractions bound or nor bound to lipoprotein and the mortality. The 3-HM concentration was increased in p…

medicine.medical_specialtyGastrointestinal bleedingCirrhosisbusiness.industryHazard ratiomedicine.diseaseConfidence intervalHelsinki declarationLiver diseaseInternal medicineAscitesmedicinemedicine.symptomComplicationbusinessSSRN Electronic Journal
researchProduct

Small bowel angiodysplasia associated with von Willebrand's disease: report of a case.

2006

The association between angiodysplasia (AD) and von Willebrand's disease (vWD) was first described by Quick in 1967. The clinical course of patients with vWD and AD is characterized by multiple admissions to hospital for gastrointestinal bleeding, necessitating transfusions of packed red cells, factor VIII, and von Willebrand factor concentrates. The therapeutic management of these patients is difficult. Both medical and endoscopic techniques have been tried, but no treatment modality has been completely successful. We describe the clinical course of a patient affected by vWD, who suffered repeated massive gastrointestinal bleeding caused by small bowel AD. Intestinal resection was the only…

medicine.medical_specialtyGastrointestinal bleedingDiseaseGastroenterologySmall BowelAngiodysplasiaVon Willebrand factorVon willebrandSurgical oncologyhemic and lymphatic diseasesInternal medicineIntestine SmallmedicineHumansAngiodysplasiabiologybusiness.industryPatient affectedvon Willebrand's disase.General MedicineMiddle Agedmedicine.diseaseSurgeryvon Willebrand Diseasesbiology.proteinSurgeryFemaleIntestinal resectionbusinessGastrointestinal HemorrhageSurgery today
researchProduct

Coexistence of Von Willebrand disease and gastrointestinal stromal tumor (G.I.S.T): Case report of a rare and challenge association

2019

Von Willebrand disease (VWD) is the most common inherited bleeding disorder and is caused by a quantitative (type 1 and 3) or qualitative (type 2) defect of Von Willebrand factor (VWF). Bleeding from the gastrointestinal (GI) tract is not uncommon in VWD and is usually associated with angiodysplasia. We report herein on the management of a patient affected by VWD2B with severe GI bleeding secondary to gastrointestinal stromal tumor (GIST) complicated by deep vein thrombosis (DVT). The current case demonstrated that the hemostatic balance, in RBDs under specific circumstances, can range from a tendency toward a hemorrhagic to normal or prothrombotic state. In these patients, a close collabor…

medicine.medical_specialtyGastrointestinal bleedingGastrointestinal Stromal TumorsDeep veinGastrointestinal stromal tumor (GIST)030204 cardiovascular system & hematologyGastroenterology03 medical and health sciences0302 clinical medicineVon Willebrand factorhemic and lymphatic diseasesInternal medicinemedicineVon Willebrand diseaseHumansAngiodysplasiaStromal tumorGastrointestinal bleedingGiSTbiologybusiness.industryHematologyMiddle Agedmedicine.diseaseThrombosisvon Willebrand DiseasesThrombotic riskmedicine.anatomical_structurebiology.proteinFemalebusinessVon Willebrand 2B030215 immunology
researchProduct

Management of complications after operations for acute pancreatitis.

1981

After early operation in 49 patients and delayed operation in 114 patients, all with acute hemorrhagic-necrotizing pancreatitis, 65% of patients developed local or general complications. Local complications were abscesses, peritonitis, bleeding, gastrointestinal fistulae or stenoses, and external pancreatic fistulae. Their cause can be traced to the large wound cavity with the tryptic wound surface as well as residual necrosis. The general postoperative complications were shock, acute renal failure, cardiorespiratory insufficiency, gastrointestinal bleeding, ileus, coagulopathy, and sepsis. These may have resulted from the local complications, or may even have been present before operation.…

medicine.medical_specialtyGastrointestinal bleedingIleusbusiness.industryPeritonitisHemorrhageAcute Kidney InjuryPeritonitismedicine.diseaseSurgeryHeart ArrestSepsisPostoperative ComplicationsPancreatitisAcute DiseasemedicineCoagulopathyAcute pancreatitisPancreatitisHumansSurgerybusinessGastrointestinal HemorrhageShock SurgicalAbdominal surgeryWorld journal of surgery
researchProduct

Fully robotic Ivor–Lewis esophagectomy (RAMIE4) for esophageal cancer after emergency surgery and ligation of the gastroduodenal artery

2018

We report a case of a 69-year-old patient with esophageal cancer and severe upper gastrointestinal bleeding during neoadjuvant radiochemotherapy who required mass transfusion followed by complex emergency procedures. Despite endoscopic stenting, the bleeding recurred, and thus emergency open surgery was required. Gastric wedge resection of the minor curvature necessitated by perforation caused by the endoscopic stent maneuver and duodenotomy with ligation of the gastroduodenal artery, as the cause of persistent intraluminal bleeding, were performed. The already prepared gastric conduit during the emergency operation did not become ischemic, even though the gastroduodenal artery, left gastr…

medicine.medical_specialtyGastrointestinal bleedingMedicine (General)Esophageal NeoplasmsDuodenumgastrointestinal bleedingHemorrhagereal-time fluoroscopyCase Reports030204 cardiovascular system & hematologyAdenocarcinomaBiochemistryIvor–Lewis esophagectomyGastroduodenal artery03 medical and health sciences0302 clinical medicineR5-920Emergency surgeryRobotic Surgical Proceduresmedicine.arteryMedicineIvor lewisHumansRobotic surgeryesophageal cancerAgedbusiness.industryBiochemistry (medical)Robotic surgeryCell BiologyGeneral MedicineArteriesChemoradiotherapy AdjuvantEsophageal cancermedicine.diseasePrognosisNeoadjuvant TherapySurgeryEsophagectomy030220 oncology & carcinogenesisgastric conduitUpper gastrointestinal bleedingbusinessLigationJournal of International Medical Research
researchProduct